2014 Drug Carriers in Medicine and Biology Gordon Research Conference and Gordon
2014年医学和生物学药物载体戈登研究会议和戈登
基本信息
- 批准号:8717902
- 负责人:
- 金额:$ 1.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-04-01 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AcademiaAddressAreaAsiaBasic ScienceBiocompatible MaterialsBiologicalBiologyCanadaChemicalsClinicClinicalCollaborationsConsultationsDataDevelopmentDrug CarriersDrug Delivery SystemsDrug TargetingEngineeringEnvironmentEuropeEye diseasesFacultyFemaleFosteringFundingFunding ApplicantFutureGenderGoalsGrowth and Development functionHeadHealthHumanImageImmunotherapyIn VitroIndustryKnowledgeLocationMedicalMedicineMinority GroupsModelingModern MedicineModificationMolecularNatureNew HampshireOrganismPatientsPersonsPharmaceutical PreparationsPharmacologic SubstancePolymer ChemistryPolymersPopulationPostdoctoral FellowProteinsResearchResearch PersonnelResearch PriorityResortScienceScientistSeasonsSmall Interfering RNASolubilityStagingStudentsSystemTestingTherapeuticTherapeutic EffectTimeTrainingTranslationsUnderrepresented MinorityVaccinesWomanWorkabstractingcancer immunotherapycancer therapycareerclinical applicationdesignenzyme therapygraduate studentimaging probeimprovedin vivoinsightmedical specialtiesmeetingsmolecular imagingmultidisciplinarynovelnovel strategiespatient orientedpostersprofessorprogramsprospectivepublic health relevancesmall moleculesymposiumtargeted deliverytraffickinguptakeworking group
项目摘要
DESCRIPTION (provided by applicant): Funding is requested for partial support of the Gordon Research Conference and associated Gordon Research Symposium on Drug Carriers in Medicine and Biology to be held in Waterville Valley Resort, New Hampshire August 16-22, 2014. This comprehensive meeting will focus on cutting edge research in drug delivery, while simultaneously providing an outstanding forum for junior and senior researchers, students and postdocs from academia and industry to engage each other. The long term goals are to foster collaboration to bring the field to an even higher level, support the growth and development of young researchers in order to increase the worker pipeline in this important topic, and to provide an avenue for translation of cutting edge research to the clinic and patients. Drug delivery is a crucial component of modern day medicine, and the design and optimization of targeted drug carriers is an important area of research. The subtopic of the GRC is "Leveraging Mechanism and Chemical Design for Improved Therapeutic Effect" and the GRS is " Molecular and Cellular." In particular, the conference will focus on the latest delivery systems and include sessions on mechanisms of carrier distribution, cellular uptake and trafficking, and new approaches to addressing hurdles. Session themes include targeted systems for delivery, new approaches to chemical modification, engineering, and conjugation for improved delivery, and transport, fate, and efficacy of drug delivery systems. Applications and exciting opportunities in ophthalmic delivery, cancer, and immunotherapy will be included in specific sessions. Clinical opportunities and translation will be a key focus of the meeting, with industrial participation to give this perspective. Speakers and discussion leaders are recognized leaders in their fields and were chosen in consultation with scientists who represent the breadth of the field of drug delivery. The GRC/GRS program reflects diversity in the population in terms of gender, career stage, location, and underrepresented minority group. In particular, this high quality program will
include talks from early career stages (graduate students and postdocs for the GRS and assistant and associate professors and young industrial researchers for the GRC), from persons of underrepresented groups, and females. Diversity will be further boosted through active recruitment and registration of faculty and trainees from underrepresented groups. This proposal seeks funding specifically for this goal. The specific objectives of the Engineering Advances in Drug Targeting GRC/GRS are: 1) To provide a forum for discussion of the latest drug carrier research. 2) To bring together a diverse group of scientists working in different areas of drug delivery design. 3) To identify priority research themes for the coming years by identifying gaps in knowledge and improving conceptual models. 4) To provide a high quality and accessible arena for interaction between trainees and senior researchers. 5) To provide an avenue for young researchers to give talks and posters and to broaden their training for their future careers.
描述(由申请人提供):要求资金在2014年8月16日至22日在新罕布什尔州沃特维尔谷度假村(Waterville Valley Resort,New Hampshire)举行的戈登研究会议和相关的戈登戈登研究研讨会。这次综合会议将集中在培养药品的尖端研究上,同时促进杰出的研究生和高级研究生,并提供其他研究生,并提供了其他学院的研究。长期的目标是促进合作,以使该领域达到更高的水平,支持年轻研究人员的成长和发展,以便在这一重要主题中增加工人管道,并为将尖端研究转化为诊所和患者提供途径。药物输送是现代医学的关键组成部分,目标药物携带者的设计和优化是研究的重要领域。 GRC的亚主题是“利用机制和化学设计,以改善治疗效果”,而GRS是“分子和细胞”。特别是,会议将重点关注最新的交付系统,并包括有关载体分配机制,蜂窝摄取和贩运的机制,以及解决障碍的新方法。会议主题包括用于交付的目标系统,化学修改的新方法,工程和共轭,以改善交付以及药物输送系统的运输,命运和功效。特定会议中将包括在眼科分娩,癌症和免疫疗法中的应用和激动人心的机会。临床机会和翻译将是会议的重点,并以工业参与为例。演讲者和讨论领导者是其领域的公认领导者,并与代表毒品传递领域的科学家协商。 GRC/GRS计划在性别,职业阶段,位置和代表性不足的少数群体方面反映了人口的多样性。特别是,这个高质量的计划将
包括早期职业阶段的会谈(GRS的研究生和博士后,助理,副教授和GRC的年轻工业研究人员),来自代表性不足的群体的人和女性。通过积极招募和登记人数不足的团体的教职员理和学员的注册,将进一步提高多样性。该提案为此目标寻求资金。工程靶向GRC/GRS的工程进展的具体目标是:1)提供一个论坛,讨论最新的药物载体研究。 2)将一组在药物输送设计不同领域工作的科学家组合在一起。 3)通过确定知识差距并改善概念模型,以确定未来几年的优先研究主题。 4)为学员和高级研究人员之间的互动提供高质量且可访问的舞台。 5)为年轻研究人员提供一条途径,以进行谈判和海报,并扩大他们对未来职业的培训。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Heather D Maynard其他文献
Heather D Maynard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Heather D Maynard', 18)}}的其他基金
Stabilization of Glucagon by Trehalose Gylcopolymer Nanogels
海藻糖乙二醇聚合物纳米凝胶对胰高血糖素的稳定性
- 批准号:
10558471 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Stabilization of Glucagon by Trehalose Gylcopolymer Nanogels
海藻糖乙二醇聚合物纳米凝胶对胰高血糖素的稳定性
- 批准号:
10372210 - 财政年份:2021
- 资助金额:
$ 1.5万 - 项目类别:
Trehalose Glycopolymers to Enhance both Pharmacokinetics and Stability of Therapeutic Proteins
海藻糖糖聚合物可增强治疗性蛋白质的药代动力学和稳定性
- 批准号:
9113714 - 财政年份:2016
- 资助金额:
$ 1.5万 - 项目类别:
Trehalose Glycopolymers to Enhance both Pharmacokinetics and Stability of Therapeutic Proteins
海藻糖糖聚合物可增强治疗性蛋白质的药代动力学和稳定性
- 批准号:
9245687 - 财政年份:2016
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8246214 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8588251 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8776294 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
Stable and Active bFGF-Polymer Conjugates for Wound Healing
用于伤口愈合的稳定且活性强的 bFGF-聚合物缀合物
- 批准号:
8398914 - 财政年份:2011
- 资助金额:
$ 1.5万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
University of Louisville Biomedical Integrative Opportunity for Mentored Experience Development -PREP (UL-BIOMED-PREP)
路易斯维尔大学生物医学综合指导经验开发机会 -PREP (UL-BIOMED-PREP)
- 批准号:
10557638 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
San Diego State University Advancing Cancer Careers for ExceLlence (ACCEL)
圣地亚哥州立大学卓越推进癌症职业 (ACCEL)
- 批准号:
10784133 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
International Conference on Cancer Health Disparities
国际癌症健康差异会议
- 批准号:
10606212 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
2023 RNA Nanotechnology Gordon Research Conference and Seminar
2023年RNA纳米技术戈登研究会议暨研讨会
- 批准号:
10598881 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别:
Develop an engineered Cas effector for in vivo cell-targeted delivery in the eye to treat autosomal dominant BEST disease
开发工程化 Cas 效应器,用于眼内体内细胞靶向递送,以治疗常染色体显性 BEST 疾病
- 批准号:
10668167 - 财政年份:2023
- 资助金额:
$ 1.5万 - 项目类别: